Literature DB >> 3773903

IgG2 deficiency and intractable epilepsy of childhood.

M Duse, S Tiberti, A Plebani, M A Avanzini, M Gardenghi, E Menegati, V Monafo, A G Ugazio.   

Abstract

Twelve children with intractable childhood epilepsy (ICE) were treated with high-dose intravenous immunoglobulins every 21 days for 6 months after immunologic and neurologic evaluations had been carried out. 50% (6/12) were found to have a deficiency of serum IgG2 and all but 1 of these responded to treatment with marked reduction in the daily number of seizures assessed both clinically and electroencephalographically. The response to treatment was, in fact, significantly higher in the children with IgG2 deficiency than in the others. IgG4 deficiency, observed in 5 children, did not affect treatment response. It is suggested that IgG2 deficiency may predispose to some form of viral encephalitis which may trigger an immune mechanism leading to the ICE.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3773903

Source DB:  PubMed          Journal:  Monogr Allergy        ISSN: 0077-0760


  11 in total

1.  Incidence of selective IgG2 deficiency in patients with vasculitis.

Authors:  A Jiménez; M López-Trascasa; G Fontán
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

Review 2.  High dose intravenous gamma-globulin in intractable epilepsy of childhood.

Authors:  A Etzioni; M Jaffe; S Pollack; N Zelnik; A Benderly; Y Tal
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

Review 3.  Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders.

Authors:  S A Schwartz
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

Review 4.  Clinical significance of IgG subclass deficiency.

Authors:  G Morgan; R J Levinsky
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

5.  Neuroinflammatory Nexus of Pediatric Epilepsy.

Authors:  Shruti Bagla; Alan A Dombkowski
Journal:  J Pediatr Epilepsy       Date:  2018-09-03

6.  Use of intravenous immunoglobulins in drug-resistant epilepsy.

Authors:  A Fois; M Vascotto
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

Review 7.  Immunoglobulin treatment in human and experimental epilepsy.

Authors:  B G van Engelen; W O Renier; C M Weemaes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

8.  High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study.

Authors:  B G van Engelen; W O Renier; C M Weemaes; P F Strengers; P J Bernsen; S L Notermans
Journal:  Eur J Pediatr       Date:  1994-10       Impact factor: 3.183

Review 9.  The use of IVIG in neurological disease.

Authors:  A I Levinson
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

10.  Intravenous immunoglobulin induces interferon-gamma and interleukin-6 in vivo.

Authors:  Z D Ling; E Yeoh; B T Webb; K Farrell; J Doucette; D S Matheson
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.